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Denis Aydin1,2, Maria Feychting3, Joachim Schüz4, Martin Röösli1,2*and CEFALO study teamAbstract
The first case–control study on mobile phone use and brain tumour risk among children and adolescents (CEFALO
study) has recently been published. In a commentary published in Environmental Health, Söderqvist and colleagues
argued that CEFALO suggests an increased brain tumour risk in relation to wireless phone use. In this article, we
respond and show why consistency checks of case–control study results with observed time trends of incidence
rates are essential, given the well described limitations of case–control studies and the steep increase of mobile
phone use among children and adolescents during the last decade. There is no plausible explanation of how a
notably increased risk from use of wireless phones would correspond to the relatively stable incidence time trends
for brain tumours among children and adolescents observed in the Nordic countries. Nevertheless, an increased risk
restricted to heavy mobile phone use, to very early life exposure, or to rare subtypes of brain tumours may be
compatible with stable incidence trends at this time and thus further monitoring of childhood brain tumour
incidence rate time trends is warranted.
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In a recent commentary [1], Söderqvist et al. discussed
the findings of our international case–control study on
mobile phone use and brain tumour risk in children and
adolescents (CEFALO study) [2]. This is a response to
their commentary.Result
Söderqvist et al. see “several indications of increased risk,
despite low exposure, [and] short latency, . . .” [1] Never-
theless, they do not provide any explanation of how such
an increased risk from use of wireless phones would cor-
respond to relatively stable incidence time trends for
brain tumours among children and adolescents in the
Nordic countries over the last 20 years [Figure 1], and
similarly stable incidence time trends in other countries
[3-5]. As shown in Figure 1 the proportion of regular* Correspondence: martin.roosli@unibas.ch
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reproduction in any medium, provided the ormobile phone users among children and adolescents has
steeply increased over the last ten years. These data are
even more incompatible if one considers their arguments
that the risk estimates observed in CEFALO are underes-
timations of the true risk because of exposure misclassifi-
cation due to cordless phone use and because of more
widespread use of wireless phones among adolescents
today compared to the time period when CEFALO was
carried out (2004–2008). Regarding the inconsistency be-
tween results from analytical studies such as CEFALO
and incidence time trends, the authors repeatedly imply
that central nervous system tumours are underreported
to the Swedish Cancer registry [1,6]. However, each time
they fail to mention that the observed underreporting
was mainly confined to patients 70 years or older [7],
which has little relevance for incidence trends in children
and adolescents, or other age-groups with high preva-
lence of mobile phone users.
As argued above, assuming a short latency of a few
years, an increased brain tumour risk should be detect-
able in the incidence data that are already available today
because of the steep increase in wireless phone usetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Age-standardized incidence rates for brain and central nervous system tumours. Rates are shown for the age group 5–19 years
living in the Nordic Countries obtained from NORDCAN (http://www-dep.iarc.fr/nordcan/English/frame.asp], accessed January 9, 2012). Regular
mobile phone use is defined as having had at least one call per week during a period of at least six months. We estimated the proportion of
regular mobile phone users in this age group by combining data from the control subjects in CEFALO with subscriber data from Sweden
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the risk is restricted to a very small subgroup of the
population, e.g. very heavy mobile phone users). For this
reason we restricted our analysis of cordless phone use
to the first three years of use. Because most children and
adolescents in CEFALO had used cordless phones earlier
in life than mobile phones, we could address the effects
of microwave radiation with longer latency time periods
or with exposure at a young age. It is striking, however,
that it was difficult for many participating families to re-
call the amount of cordless phone use early in life and
some did not feel comfortable about answering questions
about amount, duration, or years since first use. The
seemingly inconsistent numbers in the tables are actually
the consequences of missing answers to some of the
questions [table six in the original paper [2]] or due to
categories which were not mutually exclusive as
explained in the footnotes in the original article [table
four and five in the original paper].
Discussion and Conclusion
The original conclusions in the abstract and the last
paragraph of our paper [2] were that “the absence of an
exposure–response relationship either in terms of the
amount of mobile phone use or by localization of the
brain tumour argues against a causal association.” And
“we cannot, however, rule out the possibility that mobile
phones confer a small increase in risk and therefore
emphasize the importance of future studies with object-
ive exposure assessment or the use of prospectively col-
lected exposure data.” Meanwhile, all available data from
epidemiological studies should be evaluated and dis-
cussed in a balanced way, taking into account the
strengths and limitations of each respective study design.
Because of the well-described limitations of case–controlstudies with retrospectively assessed self-reported wire-
less phone use, it is imperative to check the consistency
of the observed relative risk estimates with observed
time trends of incidence rates to avoid drawing wrong
conclusions [8,9].
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